Thrivent Financial for Lutherans
OFIX icon

Thrivent Financial for Lutherans’s Orthofix Medical OFIX Stock Holding History

Thrivent Financial for Lutherans’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-33,603
Closed -$432K – 2528
2023
Q3 		$432K Buy
33,603
+392
+1% +$7.05K ﹤0.01% 2195
2023
Q2 		$600K Sell
33,211
-666
-2% -$12.4K ﹤0.01% 2106
2023
Q1 		$567K Buy
33,877
+13,354
+65% +$261K ﹤0.01% 2085
2022
Q4 		$421K Sell
20,523
-42,521
-67% -$750K ﹤0.01% 2166
2022
Q3 		$1.2M Buy
63,044
+4,821
+8% +$108K ﹤0.01% 1555
2022
Q2 		$1.37M Buy
58,223
+25,309
+77% +$725K ﹤0.01% 1483
2022
Q1 		$1.08M Buy
32,914
+13,811
+72% +$444K ﹤0.01% 1782
2021
Q4 		$594K Sell
19,103
-288
-1% -$9.63K ﹤0.01% 2127
2021
Q3 		$739K Sell
19,391
-5,328
-22% -$212K ﹤0.01% 1999
2021
Q2 		$991K Sell
24,719
-7,372
-23% -$312K ﹤0.01% 1851
2021
Q1 		$1.39M Sell
32,091
-8,655
-21% -$382K ﹤0.01% 1656
2020
Q4 		$1.75M Sell
40,746
-11,685
-22% -$427K ﹤0.01% 1401
2020
Q3 		$1.63M Sell
52,431
-9,490
-15% -$294K ﹤0.01% 1270
2020
Q2 		$1.98M Buy
61,921
+160
+0.3% +$5.31K 0.01% 1068
2020
Q1 		$1.73M Buy
61,761
+797
+1% +$30.8K 0.01% 1014
2019
Q4 		$2.82M Buy
60,964
+21,118
+53% +$993K 0.01% 885
2019
Q3 		$2.11M Buy
39,846
+167
+0.4% +$8.62K 0.01% 971
2019
Q2 		$2.1M Buy
39,679
+8,478
+27% +$451K 0.01% 972
2019
Q1 		$1.76M Buy
31,201
+17,711
+131% +$994K 0.01% 1031
2018
Q4 		$708K Buy
13,490
+296
+2% +$16.8K ﹤0.01% 1374
2018
Q3 		$763K Buy
13,194
+254
+2% +$14.2K ﹤0.01% 1451
2018
Q2 		$735K Buy
12,940
+1,183
+10% +$67.3K ﹤0.01% 1456
2018
Q1 		$691K Buy
11,757
+495
+4% +$27.7K ﹤0.01% 1444
2017
Q4 		$616K Buy
11,262
+222
+2% +$11.5K ﹤0.01% 1550
2017
Q3 		$522K Buy
11,040
+130
+1% +$6.12K ﹤0.01% 1547
2017
Q2 		$507K Buy
10,910
+870
+9% +$36.1K ﹤0.01% 1503
2017
Q1 		$383K Sell
10,040
-45,370
-82% -$1.68M ﹤0.01% 1659
2016
Q4 		$2M Sell
55,410
-30
-0.1% -$1.14K 0.01% 858
2016
Q3 		$2.37M Buy
+55,440
New +$2.47M 0.01% 816

Other funds holding OFIX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Thrivent Financial for Lutherans's OFIX Position: Q4 2023 in Review

Thrivent Financial for Lutherans sold out of Orthofix Medical (OFIX) in Q4 2023, closing a stake of 33,603 shares — an estimated $432K sold.

Thrivent Financial for Lutherans first reported a position in OFIX in Q3 2016 and held it in 29 quarters. The position peaked at $2.82M in Q4 2019. 156 funds tracked by Wall St. Rank hold OFIX as of Q4 2023.

  • Thrivent Financial for Lutherans reported no remaining Orthofix Medical position as of Q4 2023 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 33,603 Orthofix Medical shares in Q4 2023, an estimated $432K.
  • Thrivent Financial for Lutherans first reported a position in Orthofix Medical in Q3 2016 and held it in 29 quarters.
  • Thrivent Financial for Lutherans's Orthofix Medical position peaked at $2.82M in Q4 2019.
  • 156 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2023.

Based on Thrivent Financial for Lutherans's 13F filing for Q4 2023, filed 14 Feb 2024.